Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$914M |
| 2 |
Okta
OKTA
|
+$823M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$687M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$647M |
| 5 |
AT&T
T
|
+$636M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.24B |
| 2 |
Walt Disney
DIS
|
+$951M |
| 3 |
Ecolab
ECL
|
+$879M |
| 4 |
SPDR Gold Trust
GLD
|
+$558M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$505M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.24% |
| 3 | Financials | 9.62% |
| 4 | Communication Services | 7.72% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PACD
5326
DELISTED
Pacific Drilling S.A. Common Shares
PACD
| $164K | ﹤0.01% |
40,178
+31,895
| +385% | +$99.7K |
|
|
FONR
5327
DELISTED
Fonar
FONR
| $163K | ﹤0.01% |
8,267
+5,402
| +189% | +$108K |
|
|
AMOV
5328
DELISTED
America Movil SAB de CV
AMOV
| $163K | ﹤0.01% |
10,554
-205
| -2% | -$3.11K |
|
|
FLC
5329
Flaherty & Crumrine Total Return Fund
FLC
$175M
| $162K | ﹤0.01% |
7,265
-9,990
| -58% | -$225K |
|
|
FRN
5330
DELISTED
Invesco Frontier Markets ETF
FRN
| $162K | ﹤0.01% |
11,378
-5,722
| -33% | -$80.8K |
|
5331
ProShares Ultra NASDAQ Biotechnology
BIB
$77.5M
| $161K | ﹤0.01% |
2,612
+1,320
| +102% | +$70.4K |
|
5332
Teucrium Corn Fund
CORN
$170M
| $161K | ﹤0.01% |
10,850
-1,733
| -14% | -$25.7K |
|
5333
Escalade
ESCA
$291M
| $161K | ﹤0.01% |
16,375
+12,069
| +280% | +$131K |
|
|
KF
5334
Korea Fund
KF
$233M
| $161K | ﹤0.01% |
5,397
-400
| -7% | -$11.3K |
|
|
WSO.B
5335
Watsco Inc Class B
WSO.B
$13.1B
| $161K | ﹤0.01% |
900
| – | – |
|
5336
Astrana Health
ASTH
$1.79B
| $160K | ﹤0.01% |
8,666
+1,040
| +14% | +$17.2K |
|
5337
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$114M
| $159K | ﹤0.01% |
4,488
+65
| +1% | +$2.51K |
|
5338
Spero Therapeutics
SPRO
$67.7M
| $159K | ﹤0.01% |
16,554
+12,345
| +293% | +$133K |
|
5339
NextDecade
NEXT
$1.76B
| $158K | ﹤0.01% |
25,597
+14,600
| +133% | +$90.9K |
|
|
RDHL
5340
Redhill Biopharma
RDHL
$3.99M
| $158K | ﹤0.01% |
26
-12
| -32% | -$76.7K |
|
|
EWGS
5341
DELISTED
iShares MSCI Germany Small-Cap ETF
EWGS
| $158K | ﹤0.01% |
2,611
-2,123
| -45% | -$120K |
|
|
RNET
5342
DELISTED
RigNet, Inc.
RNET
| $157K | ﹤0.01% |
23,691
+6,465
| +38% | +$38.8K |
|
|
FGP
5343
DELISTED
Ferrellgas Partners, L.P.
FGP
| $157K | ﹤0.01% |
464,629
+8,224
| +2% | +$4.98K |
|
5344
SB Financial Group
SBFG
$165M
| $155K | ﹤0.01% |
8,266
+8,213
| +15,496% | +$139K |
|
5345
Saga Communications
SGA
$58.1M
| $155K | ﹤0.01% |
5,102
+4,033
| +377% | +$123K |
|
|
NYMX
5346
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $155K | ﹤0.01% |
70,387
+1,562
| +2% | +$3.08K |
|
|
IMV
5347
DELISTED
IMV Inc. Common Shares
IMV
| $155K | ﹤0.01% |
5,352
-240
| -4% | -$6.45K |
|
|
PRVB
5348
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $155K | ﹤0.01% |
10,400
-197,385
| -95% | -$1.76M |
|
5349
Kenon Holdings
KEN
$3.47B
| $154K | ﹤0.01% |
7,348
+1,393
| +23% | +$29.7K |
|
5350
MediWound
MDWD
$181M
| $154K | ﹤0.01% |
7,113
-417
| -6% | -$8.65K |
|
Similar funds
Morgan Stanley's Q4 2019 Portfolio in Review
As of Q4 2019, Morgan Stanley held 7,012 positions worth $430B, up 14% from $378B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley deployed $21.8B of net new capital in Q4 2019, opening 186 new positions and adding to 4,119 existing holdings. Its largest new stake was XChange TEC: 50 shares worth $44M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.24B trimmed.
- Morgan Stanley's largest Q4 2019 buy was XChange TEC: 50 shares worth $44M.
- Morgan Stanley added most to Uber in Q4 2019, an estimated $914M increase.
- Morgan Stanley's biggest Q4 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $1.24B.
- Morgan Stanley fully exited Buckeye Partners, L.P. in Q4 2019, selling an estimated $505M.
- Morgan Stanley's ten largest holdings make up 16% of its $430B portfolio in Q4 2019.
- Morgan Stanley opened 186 new positions and closed 188 in Q4 2019.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $430B.
Based on Morgan Stanley's 13F filing for Q4 2019, filed 14 Feb 2020.